Overview
Safety of Dialysate Sodium Individualization in Hemodialysis Patients With Intradialytic Hypotension
Status:
Terminated
Terminated
Trial end date:
2008-10-01
2008-10-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Low blood pressure (hypotension) during dialysis afflicts approximately 25% of hemodialysis patients. In this pilot study, we will evaluate the safety and effects of individualizing the sodium concentration in the dialysate according to the patient's own plasma sodium levels. We hypothesize that patients will have less thirst and less weight gain during the intervention leading to easier fluid removal and less episodes of hypotension.Phase:
Phase 1Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Yale UniversityTreatments:
Dialysis Solutions
Criteria
Inclusion Criteria:- Hemodialysis patients with intradialytic hypotension
Exclusion Criteria:
- Atrial fibrillation
- Bilateral upper extremity arteriovenous access
- Average plasma sodium >139